Clinical Trial Update: SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies [Phase 4]

View source ↗

Summary

Phase 4 study investigating pleiotropic effects of incretin-based therapies in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED